CONVERIUM

This brand name is authorized in Cyprus, Hong Kong, Romania, Singapore

Active ingredients

The drug CONVERIUM contains one active pharmaceutical ingredient (API):

1 Irbesartan UNII J0E2756Z7N - IRBESARTAN

Irbesartan is a potent, orally active, selective angiotensin-II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin-II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin-II. The selective antagonism of the angiotensin-II (AT1) receptors results in increases in plasma renin levels and angiotensin-II levels, and a decrease in plasma aldosterone concentration. Read about Irbesartan

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09CA04	Irbesartan	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 60778, 60779, 60780
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64619001, W64619002, W64619003, W64619004, W64619005, W64620001, W64620002, W64620003, W64620004, W64620005, W64621001, W64621002, W64621003, W64621004, W64621005
Country: SG	Health Sciences Authority	Identifier(s): 15235P, 15236P